This project will explore a range of molecules in mesothelioma to determine if they are clinically useful. Furthermore it will aim to collect fresh tissue prospectively so that novel markers can be investigated, which may lead to the identification of clinically relevant markers.
A collaboration to drive clinically meaningful research into mesothelioma
2014-2016
Dr Tom John, A/Prof Paul Mitchell, Dr Vinod Ganju, Prof Jonathan Cebon, Mr Simon Knight
Cancer Council Mesothelioma Grant
Olivia Newton-John Cancer Research Institute
$239,100 in 2014, $210,700 in 2015 and $100,000 in 2016